All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
about
Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained RemissionRituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma.Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.Current state of art for transplantation paradigms in peripheral T-cell lymphomas.An update in management of noncutaneous T-cell lymphomas.Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
P2860
Q35882481-A44773B0-D873-4091-BDAA-54F978BAA611Q36216133-E96DF309-BF6F-44C5-A6C8-9FF7B9006D36Q36231758-ED9445E2-2906-45C6-A1A8-7E5AE145465DQ36591293-7327B7A7-45D8-4EF3-8D0E-13AFA4FD0494Q36911495-2DA252F3-4CDD-4D11-A619-54FD198F1952Q37214534-EF1D4505-EFAC-4549-BEC5-35FE5FBA81A9Q37809085-BABED69E-148D-4821-97C3-C047AB66D6EDQ37931041-4E3ABF2D-2F98-4933-BA98-448FE8494902Q37956318-A0179910-83FD-4F20-9A3E-7E04EFD03D39Q38132821-8FF761B4-F30E-4AE7-9929-B353B103D540Q41215812-57815BE9-8C22-4D60-8117-E3A734EC47B8Q41928592-BA93B512-76C2-40BA-B025-B18C87FDA62BQ45929976-F36E5895-A5D8-4358-BD88-012F74C1AFD1Q45943406-B1879AB3-095D-4592-89AA-FD7369E7D5B4Q48301800-55BEFB20-3095-4513-8EB4-C5E970140407
P2860
All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
All aggressive lymphoma subtyp ...... Lymphomes de l'Adulte (GELA).
@en
All aggressive lymphoma subtyp ...... tude des Lymphomes de l'Adulte
@nl
type
label
All aggressive lymphoma subtyp ...... Lymphomes de l'Adulte (GELA).
@en
All aggressive lymphoma subtyp ...... tude des Lymphomes de l'Adulte
@nl
prefLabel
All aggressive lymphoma subtyp ...... Lymphomes de l'Adulte (GELA).
@en
All aggressive lymphoma subtyp ...... tude des Lymphomes de l'Adulte
@nl
P2093
P356
P1433
P1476
All aggressive lymphoma subtyp ...... s Lymphomes de l'Adulte (GELA)
@en
P2093
A Stamatoullas
C Gisselbrecht
C Thieblemont
F Morschhauser
Groupe d'Etude des Lymphomes de l'Adulte
P304
P356
10.1093/ANNONC/MDH471
P577
2004-12-01T00:00:00Z